IP Library Granted Patent US 9,976,177
Granted Patent B2
US 9,976,177 · App. 12/798,108 · Granted May 22, 2018

Chemical ligation dependent probe amplification (CLPA)

Inventor: Robert Terbrueggen (Manhattan Beach, CA)
Assignee: DXTERITY DIAGNOSTICS INCORPORATED
C12Q1/6855C12Q1/6862
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,976,177
App. No.
12/798,108
Granted
May 22, 2018
Kind
B2
Abstract

The present invention provides compositions, apparatuses and methods for detecting one or more nucleic acid targets present in a sample. Methods of the invention include utilizing two or more oligonucleotide probes that reversibly bind a target nucleic acid in close proximity to each other and possess complementary reactive ligation moieties. When such probes have bound to the target in the proper orientation, they are able to undergo a spontaneous chemical ligation reaction that yields a ligated oligonucleotide product. In one aspect, the ligation product is of variable length that correlates with a particular target. Following chemical ligation, the probes may be amplified and detected by capillary electrophoresis or microarray analysis.

Claims (48)

1. A method for detecting in a sample, comprising a plurality of sample nucleic acids of different nucleic acid sequences, the presence of at least one specific target nucleic acid sequence comprising a first and a second target domain, the domains located adjacent to one another, comprising the steps of:

(a) contacting the sample nucleic acids with a plurality of different probes sets, each probe set comprising:

(i) a first ligation probe comprising:

(1) a first probe domain complementary to said first target domain;

(2) a first non-complementary region being non-complementary to the said target nucleic acid sequence; and

(3) a 5′-ligation moiety comprising a DABSYL moiety; and

(ii) second ligation probe comprising:

(1) a second probe domain complementary to said second target domain;

(2) a second non-complementary region, being non-complementary to the said target nucleic acid sequence;

(3) a 3′ ligation moiety comprising a phosphorothioate moiety;

(b) ligating said first and second ligation probes in the absence of a ligase enzyme to form a ligation product; wherein at least one of said ligation probes comprises a variable spacer nucleic acid sequence such that each ligation product is a different length;

(c) amplifying said ligation product to form ligation amplicons under conditions whereby a fluorescent label is incorporated into said amplicons; and

(d) detecting the presence of said ligation amplicons by detecting the presence of said fluorescent label.

2. A method of claim 1 , wherein said target nucleic acid sequence is RNA and/or DNA.

3. A method of claim 1 , wherein said target nucleic acid sequence comprises unpurified RNA.

4. A method as in claim 1 , wherein said detecting step is by capillary electrophoresis.

5. A method for detecting in a sample, comprising a plurality of sample nucleic acids of different nucleic acid sequences, the presence of at least one specific target nucleic acid sequence comprising a first and a second target domain, the domains located adjacent to one another, comprising the steps of:

(a) contacting the sample nucleic acids with a plurality of different probes sets, each probe set comprising:

(i) a first ligation probe comprising:

(1) a first probe domain complementary to said first target domain;

(2) a first non-complementary region being non-complementary to the said target nucleic acid sequence; and

(3) a 5′-ligation moiety comprising a halogen leaving group; and

(ii) second ligation probe comprising:

(1) a second probe domain complementary to said second target domain;

(2) a second non-complementary region, being non-complementary to the said target nucleic acid sequence;

(3) a 3′ ligation moiety comprising a phosphorothioate moiety;

(b) ligating said first and second ligation probes in the absence of a ligase enzyme to form a ligation product; wherein at least one of said ligation probes comprises a variable spacer nucleic acid sequence such that each ligation product is a different length;

(c) amplifying said ligation product to form ligation amplicons under conditions whereby a fluorescent label is incorporated into said amplicons; and

(d) detecting the presence of said ligation amplicons by detecting the presence of said fluorescent label.

6. A method of claim 5 , wherein said target nucleic acid sequence is RNA and/or DNA.

7. A method of claim 5 , wherein said target nucleic acid sequence comprises unpurified RNA.

8. A method as in claim 5 , wherein said detecting step is by capillary electrophoresis.

9. A method for detecting in a sample, comprising a plurality of sample nucleic acids of different nucleic acid sequences, the presence of at least one specific target nucleic acid sequence comprising a first and a second target domain, the domains located adjacent to one another, comprising the steps of:

(a) contacting the sample nucleic acids with a plurality of different probes sets, each probe set comprising:

(i) a first ligation probe comprising:

(1) a first probe domain complementary to said first target domain;

(2) a first non-complementary region being non-complementary to the said target nucleic acid sequence; and

(3) a 5′-ligation moiety comprising a leaving group; and

(ii) second ligation probe comprising:

(1) a second probe domain complementary to said second target domain;

(2) a second non-complementary region, being non-complementary to the said target nucleic acid sequence;

(3) a 3′ ligation moiety comprising a nucleophilic group;

(b) ligating said first and second ligation probes in the absence of a ligase enzyme to form a ligation product; wherein at least one of said ligation probes comprises a variable spacer nucleic acid sequence such that each ligation product is a different length;

(c) amplifying said ligation product to form ligation amplicons under conditions whereby a fluorescent label is incorporated into said amplicons; and

(d) detecting the presence of said ligation amplicons by detecting the presence of said fluorescent label.

10. A method of claim 9 , wherein said target nucleic acid sequence is RNA and/or DNA.

11. A method of claim 9 , wherein said target nucleic acid sequence comprises unpurified RNA.

12. A method as in claim 9 , wherein said detecting step is by capillary electrophoresis.

Assignments (5)
SECURITY INTEREST Recorded Jul 10, 2015
From: DXTERITY DIAGNOSTICS INCORPORATED
To: SILICON VALLEY BANK
Reel/Frame 036061/0144 →
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2015
From: SILICON VALLEY BANK
To: DXTERITY DIAGNOSTICS
Reel/Frame 035438/0992 →
SECURITY INTEREST Recorded Apr 17, 2015
From: DXTERITY DIAGNOSTICS INCORPORATED
To: SWK FUNDING LLC
Reel/Frame 035439/0279 →
SECURITY AGREEMENT Recorded Sep 4, 2013
From: DXTERITY DIAGNOSTICS INCORPORATED
To: SILICON VALLEY BANK
Reel/Frame 031156/0570 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2010
From: TERBRUEGGEN, ROBERT H.
To: DXTERITY DIAGNOSTICS
Reel/Frame 024199/0913 →
Continuity (2)
Provisional Application 61165839 · Apr 1, 2009
Related Publication 20100267585A1 · Oct 21, 2010